UCSF appeals USPTO panel judgment in favor of InSite Vision

InSite Vision Incorporated (OTCBB:INSV) today announced that the University of California, San Francisco (UCSF) has appealed the judgment of the United States Patent and Trademark Office (USPTO) panel that found in favor of the Company in its patent interference litigation with UCSF. The USPTO panel of judges entered judgment in favor of InSite Vision and confirmed the inventorship of InSite Vision's U.S. Patent Nos. 6,239,113 and 6,569,443 protecting AzaSite® on November 25, 2011. The appeal was filed by UCSF with the U.S. Court of Appeals for the Federal Circuit in Washington, D.C. on December 23, 2011.

"We are disappointed that UCSF has chosen to appeal the judgment of the USPTO in this case," said Timothy Ruane, InSite Vision's Chief Executive Officer. "We strongly believe that the UCSF claims are entirely without merit as confirmed by the USPTO and we will continue to vigorously defend our position."

Source: InSite Vision Incorporated


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment